EVERSANA has expanded its AI-powered commercialization platform with new capabilities for medical affairs, market research, and field sales team engagement. The additions extend the platform beyond its original focus on marketing agency operations, giving life sciences organizations a broader set of tools for content development, knowledge management, and commercial workflows.
The company's AI Agency combines agentic AI orchestration, workflow automation, and enterprise data capabilities. Newly available functions include solutions for medical information, market research, MLR automation, and analytics. EVERSANA said additional innovations are in development across market access, patient services, and sales enablement.
From pilots to production
The expansion reflects a shift in how pharmaceutical companies approach AI adoption. Instead of running isolated experiments, organizations are looking for ways to scale AI across entire commercialization operations while keeping governance and compliance intact.
"The pharmaceutical industry has reached an inflection point," said Mark Thierer, Chief Executive Officer of EVERSANA. "Organizations are moving beyond isolated AI pilots and looking for practical ways to scale AI across commercialization. We're helping clients take meaningful steps toward a more connected, efficient and AI-enabled operating model that complements human expertise while maintaining the governance and compliance our industry demands."
The platform is designed to let companies securely use enterprise knowledge, reusable content, and AI-powered workflows while meeting the regulatory requirements that apply to life sciences work. For operations teams, that means a single system for content development, review, and distribution across multiple commercial functions.
Operational impact
For operations professionals, the practical benefit is in workflow speed. The platform automates repetitive steps in content production and medical review, shortens review cycles, and gives teams a shared repository of approved content and knowledge. That reduces the time spent re-creating materials and makes it easier to keep messaging consistent across teams.
The platform also supports faster decision-making, since analytics and knowledge management are built into the same workflow layer. Instead of switching between systems, teams can access insights and content within the context of the task they're working on.
The system is also relevant for operations managers looking to apply AI to their own workflows. Teams evaluating vendor platforms like EVERSANA's will need to understand how agentic orchestration and workflow automation work in practice. AI for Operations covers the underlying concepts that make these systems function, including how to structure data and processes for automation.
Why this matters for operations
The operational takeaway is concrete: content development, review, and approval cycles in pharma commercialization are heavy manual processes. EVERSANA is betting that integrating AI into the workflow layer will reduce cycle times and free up teams for higher-value work. For operations leaders, the practical question is whether their own content supply chains are ready for this kind of automation. That means auditing current processes, identifying bottlenecks, and understanding where AI can realistically help before committing to a platform. An AI Learning Path for Operations Managers can help with that evaluation.
EVERSANA plans to introduce additional capabilities as the platform develops, with the stated goal of helping clients improve collaboration and speed delivery of therapies to patients.
Your membership also unlocks:
